الأصول تغيير تاريخ
AbbVie USD 147.68B 12.57B 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Gilead Sciences USD 51.41B 2.05B 2026-09
Immunic USD 136.42M 22.75M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Merck USD 132.77B 2.97B 2026-09